Clearmind Medicine CMND Ratios (2021-2026)

NASDAQ CMND
$1.79 +0.06 (+3.83%)
As of: Aug 21, 2026 · 2:57 PM EDT
Ratios Oct2021 Jan2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Profitability
EBT Margin (Quarter) 10,915.38%
EBIT Margin (Quarter) 10,903.17%
EBITDA Margin (Quarter) 10,903.17%
Net Margin (Quarter) 10,688.75%
FCF Margin (Quarter) 5,995.54%
Efficiency
Assets Average (Quarter) 2.73M5.30M5.24M5.22M8.03M9.47M8.51M7.71M6.92M5.88M4.58M5.03M8.61M12.83M
Invested Capital (Quarter) 0.05M1.24M0.79M0.04M0.04M0.85M0.05M0.05M0.63M0.75M0.56M0.73M0.06M0.23M0.10M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -322.471.00-0.00M-2.98-0.00M-1.17M-534.30-892.82-796.26-806.74-723.17-0.00M-2.67-75.30-3.05
Debt Ratio (Quarter) 0.000.250.020.010.010.020.010.010.010.010.010.010.010.020.01
Times Interest Earned (Quarter) -322.471.00-0.00M-2.98-0.00M-1.17M-534.30-892.82-796.26-806.74-723.17-0.00M-2.67-75.30-3.05
Dividends & Payouts
FCF Payout Ratio (Quarter) -1.57-0.11-1.101.02-6.350.820.56-4.571.190.90-4.44-1.22
Valuation
Enterprise Value (Quarter) -3.67M-2.22M-0.15M-3.35M-3.93M-5.51M-9.33M-8.35M-7.69M-6.86M-5.92M-4.65M-3.50M-5.59M-10.35M-13.59M
Return Ratios
Return on Sales (Quarter) 1.07%
Return on Capital Employed (Quarter) -3,072.72%-234.94%-126.97%-212.82%-146.51%-160.02%-166.67%-255.03%-2,685.30%-112.42%-73.07%
Return on Invested Capital (Quarter) -0.05%-0.08%-0.07%-0.08%-0.04%-0.04%-0.03%-0.02%-0.02%-0.04%-0.05%
Return on Assets (Quarter) -0.02%-0.01%-0.01%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%